KRCA-0713
Code | Size | Price |
---|
TAR-T27741-5mg | 5mg | £850.00 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here. |
Quantity:
TAR-T27741-50mg | 50mg | £1,661.00 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here. |
Quantity:
TAR-T27741-100mg | 100mg | £2,079.00 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here. |
Quantity:
Prices exclude any Taxes / VAT
Overview
Regulatory Status: RUO
Shipping:
cool pack
Storage:
-20℃
Images
Documents
Further Information
Bioactivity:
KRCA-0713 is a ALK inhibitor.
CAS:
1884321-89-4
Formula:
C26H32ClN5O3S
Molecular Weight:
530.08
Purity:
0.98
SMILES:
COc1cc2c(CCC(N)C2(C)C)cc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1
References
1. Achary R, Mathi GR, Lee DH, Yun CS, Lee CO, Kim HR, Park CH, Kim P, Hwang JY. Novel 2,4-diaminopyrimidines bearing fused tricyclic ring moiety for anaplastic lymphoma kinase (ALK) inhibitor. Bioorg Med Chem Lett. 2017 May 15;27(10):2185-2191. doi: 10.1016/j.bmcl.2017.03.073. Epub 2017 Mar 29. PubMed PMID: 28385505.